Who Paid My Doc
BioNTech SE and AbbVie, Inc., side by side
Reported CMS Open Payments figures for two companies, in the order you chose them. A comparison, not a ranking — and a payment record is not evidence of wrongdoing.
BioNTech SE
Germany
AbbVie, Inc.
IL, United States
All reported years
| Record | General | Research | Years |
|---|---|---|---|
| BioNTech SE | $2,318,991,751 | $78,879,099 | 2021–2025 |
| AbbVie, Inc. | $874,461,854 | $2,074,838,552 | 2019–2025 |
- BioNTech SE
- AbbVie, Inc.
Show as a table
| Year | BioNTech SE | AbbVie, Inc. |
|---|---|---|
| 2019 | $0 | $60,910,870 |
| 2020 | $0 | $26,135,636 |
| 2021 | $517,137,581 | $97,637,830 |
| 2022 | $716,984,192 | $143,914,703 |
| 2023 | $367,885,405 | $187,442,971 |
| 2024 | $180,574,537 | $156,729,107 |
| 2025 | $536,410,036 | $201,690,737 |
Royalty or License
BioNTech SE
$2,317,898,125
AbbVie, Inc.
$111,891,157
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
BioNTech SE
$263,297
AbbVie, Inc.
$357,904,652
Food and Beverage
BioNTech SE
$14,130
AbbVie, Inc.
$166,687,134
Acquisitions
BioNTech SE
—
AbbVie, Inc.
$79,248,950
Consulting Fee
BioNTech SE
$621,383
AbbVie, Inc.
$77,491,886
Travel and Lodging
BioNTech SE
$191,816
AbbVie, Inc.
$41,884,400
Recipients they share
From each one's top tenNothing in common among their top ten. That is a finding about the top ten only — a smaller payment in common would not show here.
Compare up to four at once, and keep your picks on every device, in the app.